Are you Dr. Meda?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2619 16th Ave S
Great Falls, MT 59405Phone+1 406-315-3398Fax+1 406-315-3400
Summary
- Dr. Brenton Meda, MD is a board certified pathologist in Great Falls, Montana. He is currently licensed to practice medicine in Montana, Pennsylvania, and Maryland. He is affiliated with UPMC Western Maryland.
Education & Training
- University of Utah HealthFellowship, Hematopathology, 1999 - 2000
- Wake Forest University Baptist Medical CenterResidency, Pathology-Anatomic and Clinical, 1998 - 1999
- West Virginia UniversityResidency, Pathology-Anatomic and Clinical, 1994 - 1997
- Medical College of WisconsinClass of 1994
Certifications & Licensure
- MD State Medical License 2022 - 2025
- MT State Medical License 2000 - 2025
- PA State Medical License 2024 - 2024
- ID State Medical License 2018 - 2021
- FL State Medical License 2017 - 2020
- WA State Medical License 2017 - 2020
- AK State Medical License 2018 - 2018
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 160 citationsDiagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry.Brenton A. Meda, David H. Buss, Ralph D. Woodruff, James O. Cappellari, Robert O. Rainer
American Journal of Clinical Pathology. 2000-05-01 - 12 citationsBCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissue.Brenton A. Meda, Michael Frost, James Newell, Sandra D. Bohling, David R. Huebner-Chan
The American Journal of Surgical Pathology. 2003-07-01 - 8 citationsMarginal zone and mantle cell lymphomas: assessment of cytomorphology in subtyping small B-cell lymphomas.Bettina A. Murphy, Brenton A. Meda, David H. Buss, Kim R. Geisinger
Diagnostic Cytopathology. 2003-03-01